Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply.
Saved in:
| Title: | Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply. |
|---|---|
| Authors: | Gunn D; NIHR Nottingham Digestive Diseases Biomedical Research Centre, University of Nottingham, Nottingham, UK.; Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Ford A; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Farrin A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Spiller R; NIHR Nottingham Digestive Diseases Biomedical Research Centre, University of Nottingham, Nottingham, UK.; Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jun; Vol. 57 (11), pp. 1337-1338. |
| Publication Type: | Editorial; Research Support, Non-U.S. Gov't; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
